CureVac
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CureVac and other ETFs, options, and stocks.About CVAC
CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). Its product portfolio includes clinical and preclinical candidates across multiple disease indications in prophylactic vaccines, oncology, and protein therapy.
CEOAlexander Zehnder
CEOAlexander Zehnder
Employees983
Employees983
HeadquartersTübingen, Baden Wuerttemberg
HeadquartersTübingen, Baden Wuerttemberg
Founded2020
Founded2020
Employees983
Employees983
CVAC Key Statistics
Market cap1.23B
Market cap1.23B
Price-Earnings ratio5.90
Price-Earnings ratio5.90
Dividend yield—
Dividend yield—
Average volume3.67M
Average volume3.67M
High today$5.50
High today$5.50
Low today$5.28
Low today$5.28
Open price$5.30
Open price$5.30
Volume1.12M
Volume1.12M
52 Week high$5.72
52 Week high$5.72
52 Week low$2.37
52 Week low$2.37
Analyst ratings
71%
of 7 ratingsBuy
28.6%
Hold
71.4%
Sell
0%
People also own
Based on the portfolios of people who own CVAC. This list is generated using Robinhood data, and it’s not a recommendation.